文献速递肺血管病与心包/心肌炎

肺血管疾病谱的临床特征与无移植生存:PVDOMICS研究

Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

PVDOMICS是一项横断面精准医学研究,纳入1,193例受试者,涵盖WSPH第1-5组肺动脉高压、疾病对照及健康对照。研究发现38.9%的PH受试者存在多个WSPH组别,第3组PH无移植生存最差,并揭示了组1-3弥散功能降低、组1-4右房容积指数增大等共享特征。

要点

  • 38.9%的PH受试者存在多个WSPH组别重叠。
  • 第3组PH的无移植生存最差。
  • 组1-3 PH弥散功能显著低于各自对照,组1-4右房容积指数高于对照。

核心结论

  • PVDOMICS队列涵盖轻度和混合病因的肺血管疾病,第3组PH无移植生存最差。
  • 组1-3 PH共享低弥散功能、组1-4 PH共享右房容积指数增大,组1 PH常见磨玻璃影和睡眠异常。

研究设计与样本

  • 横断面研究纳入1,193例受试者,包括WSPH第1-5组PH、疾病对照和健康对照。
  • 采用标准统计检验比较组间差异,包括log-rank检验比较移植或死亡时间。

主要发现

  • 38.9%的PH受试者存在多个WSPH组别。
  • 组1、3、4 PH夜间血氧饱和度下降较对照组更常见。
  • 50.2%的组1 PH受试者胸部CT可见磨玻璃影。
  • 组1-3 PH的弥散功能显著低于各自对照,组1-4的右房容积指数高于对照。
  • 110例受试者平均肺动脉压为21-24 mm Hg,第3组PH无移植生存最差。

临床怎么用

  • 应关注PH患者多组别重叠现象,避免单一分类遗漏混合病因。
  • 组1-3 PH需评估弥散功能,组1-4 PH需关注右房容积指数。
  • 第3组PH无移植生存最差,临床应加强随访和移植评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: PVDOMICS (Pulmonary Vascular Disease Phenomics) is a precision medicine initiative to characterize pulmonary vascular disease (PVD) using deep phenotyping. PVDOMICS tests the hypothesis that integration of clinical metrics with omic measures will enhance understanding of PVD and facilitate an updated PVD classification. OBJECTIVES: The purpose of this study was to describe clinical characteristics and transplant-free survival in the PVDOMICS cohort. METHODS: Subjects with World Symposium Pulmonary Hypertension (WSPH) group 1-5 PH, disease comparators with similar underlying diseases and mild or no PH and healthy control subjects enrolled in a cross-sectional study. PH groups, comparators were compared using standard statistical tests including log-rank tests for comparing time to transplant or death. RESULTS: A total of 1,193 subjects were included. Multiple WSPH groups were identified in 38.9% of PH subjects. Nocturnal desaturation was more frequently observed in groups 1, 3, and 4 PH vs comparators. A total of 50.2% of group 1 PH subjects had ground glass opacities on chest computed tomography. Diffusing capacity for carbon monoxide was significantly lower in groups 1-3 PH than their respective comparators. Right atrial volume index was higher in WSPH groups 1-4 than comparators. A total of 110 participants had a mean pulmonary artery pressure of 21-24 mm Hg. Transplant-free survival was poorest in group 3 PH. CONCLUSIONS: PVDOMICS enrolled subjects across the spectrum of PVD, including mild and mixed etiology PH. Novel findings include low diffusing capacity for carbon monoxide and enlarged right atrial volume index as shared features of groups 1-3 and 1-4 PH, respectively; unexpected, frequent presence of ground glass opacities on computed tomography; and sleep alterations in group 1 PH, and poorest survival in group 3 PH. PVDOMICS will facilitate a new understanding of PVD and refine the current PVD classification. (Pulmonary Vascular Disease Phenomics Program PVDOMICS [PVDOMICS]; NCT02980887).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Hemnes AR, Leopold JA, Radeva MK, et al. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. J Am Coll Cardiol. 2022. PMID: 35953136. doi:10.1016/j.jacc.2022.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。